Frequency cancer therapy has been shown to significantly diminish the growth of various tumors, such as breast cancer, liver and lung tumors, uterine tumors and lymphoma.
Human Hepatocellular Carcinoma (HCC) xenografts exposed to low frequency magnetic fields at cancer-specific envelope wave frequencies showed either shrinkage or reduced tumor growth depending on frequency selection (9). The outcomes depended on frequency selection.
Benefits
Cancer therapy aims to stop tumor growth by disrupting signals that cause cancer cells to divide out of control. Under normal circumstances, cells only divide when receiving strong signals from proteins that bind them; however, cancer cells often have altered versions of these proteins which prompt them to divide even when not necessary for body. Frequency cancer therapy interrupts these signals and thus curtails uncontrolled tumor cell growth.
Radiofrequency ablation (RFA) is a minimally invasive cancer treatment using electrical energy to destroy cancer cells. Often used on single tumors or small areas within larger tumors, RFA may also be combined with other therapies as a standalone or combination therapy option.
RFA delivers a localized ablative lesion at the tumor site by employing high frequency alternating current and oscillating RF waves to heat tissue near a needle electrode, via ionic heating caused by oscillating RF wave oscillations. Ionic heating causes focal coagulative necrosis that destroys cancer cells while sparing nearby healthy tissues. RFA may be carried out using an open, laparoscopic or image guided percutaneous approach and under local or general anesthesia.
Radiation therapy works to eradicate cancer cells by subjecting them to high-energy radiation beams, usually combined with other cancer therapies to accelerate cell death. Radiation therapy comes in various forms including X-rays, electron beam radiation and proton beam radiation therapy.
Particle beam radiation uses high-energy particles to destroy cancer cells and shrink tumors, often in combination with chemotherapy or surgery treatments.
Resection remains the standard treatment option for most solid tumors; however, for patients who may have co-existing medical issues or limited functionality status it may not be an appropriate treatment choice and can result in significant morbidity and mortality risks. Thus ablative approaches have been developed that aim to control local tumor growth, prevent recurrences and alleviate symptoms in this group of patients.
Safety
Researchers have discovered that cancer cells emit an unique frequency that can be detected with sensors. This information can help detect, target and treat these cancer cells effectively as well as potentially reduce side effects associated with chemotherapy or other traditional treatments.
Studies on breast cancer, for example, have demonstrated that low frequency micro frequencies (LF-MFs) can inhibit cancer cell proliferation by modulating the AKT signaling pathway and the optimal frequency for this effect is 200Hz; however, more research needs to be conducted in order to ascertain if this finding can be translated clinically.
Histotripsy is an innovative noninvasive cancer treatment method that employs electric currents to kill tumor cells. To perform it, needles must be inserted directly into the site of the tumor before passing an RF electrode through. Electric current passes through, heating up the electrode and thus killing off cancerous cells around it.
Intensity-modulated radiation therapy (IMRT) is an advanced cancer treatment technique that combines CT or MRI imaging with linear accelerator programming to generate an exact 3-D image of the tumour, which can then be programmed into the linear accelerator. This allows multiple radiation beams to be directed precisely at different parts of the tumour while decreasing radiation dose to normal tissues. The technique has been successfully utilized both external and internal cancer treatment including lymphoma and hepatocellular carcinoma. Unfortunately it’s not suitable for all patients or types of cancer;
Dosage
Chemotherapy doctors know the aim of chemotherapy is to create an optimal dose for attacking tumor cells while sparing healthy tissues, or what’s known as the maximum tolerated dose (MTD). But with newer therapies such as immunotherapies that target specific proteins involved with cancer cell development, researchers are discovering that its optimal dose might actually be lower than what patients can tolerate.
Doctors typically employ imaging devices like computed tomography (CT), magnetic resonance imaging (MRI) and/or positron emission tomography (PET) scans to track your tumour’s location during treatment and administer radiation more precisely. They may also utilize image-guided radiation therapy (IGRT), which combines CT scans, MRI or PET scans with linear accelerators so computers can monitor changes between sessions and adjust radiation dose accordingly.
Approach is especially beneficial for treating brain, lung, abdomen and prostate tumors where movement may occur during treatment. The treatment typically takes place as an outpatient at a cancer centre where a table moves around you giving multiple angles of radiation from different directions.
CyberKnife radiotherapy is an alternative to conventional LINAC-based radiation treatments used for lung, spine, and brain cancer treatment. It features a robotic arm mounted onto a linear accelerator equipped with multiple X-ray cameras that monitor the position of your tumour during each treatment session – should any movement occur between sessions, the system will automatically reposition itself so as not to miss its target area – particularly useful for lung tumors as breathing movements can significantly diminish traditional radiotherapy accuracy.
Though Bhatia’s research may not cover every cancer type, she hopes it can assist clinicians in creating long-term treatment plans for melanoma and Merkel cell carcinoma, both of which can be treated with ICIs. By decreasing dosing frequency they could save patients as well as health care systems time and money while still providing lifesaving treatments.
Side Effects
Frequency cancer therapy may lead to side effects like fatigue and sore, red skin in the area where radiation enters your body. Although less intense than some other cancer treatments, frequency cancer therapy‘s side effects can still be manageable with plenty of sleep, short naps, eating healthy meals that are balanced in nutrition and plenty of fluid intake; in order to stay hydrated while receiving enough iron and calcium.
Radiation therapy can also have adverse effects on your eyes, such as blurry vision and dry, itchy eyes. Your doctor may provide eye drops or provide special glasses during radiation treatments for you to wear. Furthermore, radiation may lead to mild headaches or muscle soreness in the area where radiation treatment takes place.
Your doctor might use radiofrequency ablation (RFA) to kill cancer cells or relieve pain caused by osteosarcoma and hepatocellular carcinoma bone tumours, among others. You could undergo RFA alone or as part of chemotherapy or surgery treatments.
Under this procedure, your doctor inserts a needle electrode into the tumor site and uses an electrical current to heat it up to high temperatures, inflicting thermal burns on cancerous cells to eliminate them and stop future tumor growth. You may require multiple RFA sessions until you can control or stop growth completely; outpatient procedures are usually available, although overnight observation may be necessary.
RFA therapy can be used to treat both primary and secondary cancers. Primary cancer occurs where it first started, while secondary cancer occurs when cancer has spread from another part of your body to form a tumour in another location where RFA will be performed.
RFA may not remove all cancerous cells or that the tumor recurs after treatment (recurrence), in which case further treatments will likely be necessary to address that area. If this occurs, additional RFA sessions might be needed in that region to address it effectively.
Anti-cancer drugs may damage ovaries and cause menstruation to stop, or completely cease (amenorrhea). This might be permanent; therefore if you want to become pregnant while taking anti-cancer treatment it would be prudent to discuss birth control options prior to beginning treatment.
